Mpox Medicine Tecovirimat: When an epidemic spreads, we trust medicines the most, but what happens when the most effective medicine starts becoming ineffective

Mpox Medicine Tecovirimat: When an epidemic spreads, we trust medicines the most, but what happens when the most effective medicine starts becoming ineffective?

Monkey Pox Medicine: After the entry of monkeypox in Europe and Asia, the fear of this disease is increasing a lot. The World Health Organization has also expressed concern about this. Many experts believe that in the coming time, this can prove to be as dangerous as the coronavirus epidemic.

This medicine for monkeypox is becoming ineffective

However, now worrying news is coming out about its medicine. Scientists have informed that the antiviral drug Tecovirimat is not effective on the Clade-1 strain of monkeypox. At present, this strain is spreading rapidly. The previous wave of monkeypox was controlled with the help of Tecovirimat medicine.

'Wounds are not healing'

According to scientists, new research has revealed that when the antiviral medicine tecovirimat is applied to the wounds of the Clade-1 strain, it does not have any significant effect. This medicine is also famous by the name of TPOXX. Scientists are also checking whether it is able to reduce the duration of the effect of monkeypox in children and adults in the Democratic Republic of Congo. The Clade-1 strain of monkeypox virus has been wreaking havoc in this country since September 2023.

This medicine was made for smallpox

Talking about the history of the drug Tecovirimat, it was developed for the treatment of smallpox. This medicine was approved by the US Food and Drug Administration. Monkeypox and smallpox are quite similar, but monkeypox is more dangerous than smallpox. Research conducted at the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health has found that the drug Tecovirimat is safe, but the health of people suffering from the Clade-1 strain is not improving.